Current markers include plasma levels of chromogranin A, tumor metastases and Ki67 staining to determine the tumor proliferation rate. Previous studies have shown that FDG-PET for neuroendocrine ...

M: Metastasis; N: Node; T: Tumor. Data from [21]. Neuroendocrine tumors have demonstrated an increase in incidence and prevalence over the past decades, partly due to increased awareness ...

Pathologist Michael Roehrl is part of a multidisciplinary team that evaluates and treats hundreds of people with neuroendocrine tumors every year. At Memorial Sloan Kettering Cancer Center, our ...

This combination has “the potential to become a new standard first-line treatment” for well-differentiated grade 1/2 gastroenteropancreatic neuroendocrine tumors with poor prognostic factors ...

More information: Rodrigo Romero et al, The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1, Nature Cancer (2024). DOI: 10.1038/s43018-024-00838-6 Provided by ...